METABOLEX ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES
Hayward, Calif., (October 12, 2005): Metabolex, Inc. today announced that Harold E. Van Wart, Ph.D., president and CEO of Metabolex, will present at three upcoming conferences in October and November.
BIO InvestorForum 2005 on Wednesday, October 19, at 9:10 a.m. as part of a panel on diabetes and at 3:00 p.m. at The Palace Hotel in San Francisco
Rodman & Renshaw Techvest 7th Annual Healthcare Conference on Monday, November 7, at 12:40 p.m. at the New York Palace Hotel in New York
CIBC World Markets 16th Annual Healthcare Conference on Tuesday, November 8, at 3:30 p.m. at The Waldorf-Astoria in New York
About
Metabolex
Metabolex is a privately held biotechnology company dedicated to the discovery and development of novel therapeutics to transform the treatment of diabetes and related metabolic disorders. Metabolex has drawn on its deep understanding of diabetes to create the largest database of genes involved in diabetes and to build a rich pipeline of product candidates and drug discovery targets. The company’s clinical program is focused on developing next-generation insulin sensitizers that lower blood glucose without the serious safety and tolerability issues associated with currently marketed products.
For additional information about Metabolex and its development pipeline, visit
www.metabolex.com.
